Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar Lcrazylegs84 (< 20) Submitted: 9/21/2011 9:02:03 PM : Outperform Start Price: $2.13 OREX Score: +39.69

Its ready to make me some money!!!

Featured Broker Partners


Advertisement